Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 67.00
+0.10 (0.15%)
May 29, 2026, 1:51 PM CST
Sinew Pharma Revenue
In the year 2025, Sinew Pharma had annual revenue of 47.00K TWD. Sinew Pharma had revenue of 47.00K in the half year ending December 31, 2025.
Revenue
47.00K
Revenue Growth
n/a
P/S Ratio
101,624.64
Revenue / Employee
824.56
Employees
57
Market Cap
4.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 328.00K | -5.90M | -94.73% |
| Dec 31, 2021 | 6.23M | 5.77M | 1,248.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.39B |
| Panion & Bf Biotech | 2.10B |
| Medigen Biotechnology | 1.34B |
| Mycenax Biotech | 815.34M |
| Pharmosa Biopharm | 69.06M |
| OBI Pharma | 49.68M |
| ACRO Biomedical | 38.26M |
| UnicoCell Biomed | 26.54M |